NCT04997044

Brief Summary

The management of cerebral palsy is complex and requires a multidisciplinary approach. Selective dorsal rhizotomy is a neurosurgical technique that aims to reduce spasticity in the lower limbs and improve motor function.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
42

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 20, 2020

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

August 4, 2021

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 9, 2021

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2022

Completed
Last Updated

December 7, 2022

Status Verified

December 1, 2022

Enrollment Period

1.7 years

First QC Date

August 4, 2021

Last Update Submit

December 6, 2022

Conditions

Keywords

standard orthotic managementSelective dorsal rhizotomyBilateral Cerebral PalsyFunctional balanceEnergy Cost of WalkingFunctional capacitySelective voluntary motor control:

Outcome Measures

Primary Outcomes (2)

  • Functional Balance

    The pediatric balance scale was used to assess the child's functional performance with total score is 56 and higher score representing a better performance.

    after 6 months and after 1 year (follow-up)

  • Gross motor function

    The gross motor function measure-88 is used to evaluate the motor function with total score is 100 and higher scores representing a better performance.

    after 6 months and after 1 year (follow-up)

Secondary Outcomes (3)

  • Selective voluntary motor control

    after 6 months and after 1 year (follow-up)

  • Energy cost of walking

    after 6 months and after 1 year (follow-up)

  • Functional capacity

    after 6 months and after 1 year (follow-up)

Study Arms (2)

control group

OTHER

control group

Other: Concomitant physical rehabilitationOther: Standard Orthotic Management

Experimental group

EXPERIMENTAL

selective dorsal rhizotomy group

Other: Concomitant physical rehabilitationOther: Standard Orthotic ManagementOther: selective dorsal rhizotomy

Interventions

Children of this group will receive a regular exercise rehabilitation program including starching exercises, functional strength training and static and dynamic balance exercises.The program will be conducted by six licensed pediatric physical therapists for one hour/session, 3 times/week, and six successive months.

Experimental groupcontrol group

A custom-made articulating ankle foot orthosis was prescribed with a hinge at the level of the medial malleolus extends distally to the tip of the toes and proximally on the posterior surface of the leg to about 5 cm below the knee and secured straps. It is fabricated to permit free ankle dorsiflexion and lock the plantar flexion at 0 dorsiflexion. The splinting schedule started gradually for 2 h/day in the first month, 4 h/day in the second month to the entire wake-up time of the day.

Experimental groupcontrol group

The surgical procedures were tailored to each child according to preoperative assessment plan. All SDRs were performed by a single neurosurgeon through an osteoplastic laminotomy from L2 to L5 that left the facet joints intact.

Experimental group

Eligibility Criteria

Age4 Years - 8 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • CP, spastic diplegia
  • years of age
  • The ability to walk with or without assistive devices typically on Level II-III on Gross Motor Function Classification System
  • At least six months after the last Botulinum toxin A injection in the lower extremities
  • Average intelligent quotient according to medical records for active participation
  • Good trunk control with good antigravity strength of lower extremity on clinical examination.
  • Ankle clonus; exaggerated deep tendon reflex in the legs
  • Babinski sign
  • Structural non-reducible deformities or musculoskeletal surgery in the lower extremities in the past 12 months
  • Moderate to severe signs of dystonia, athetosis or ataxia.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Amira Mahmoud Abd-elmonem

Giza, 12662, Egypt

Location

MeSH Terms

Conditions

Cerebral Palsy

Condition Hierarchy (Ancestors)

Brain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Officials

  • Hazem A Aly, Phd

    PhD of physical therapy for pediatrics, faculty of physical therapyCairo university

    STUDY CHAIR
  • Ahmed Rabie, Phd

    Department of neurosurgery, faculty of medicine , Alexandria university

    STUDY DIRECTOR
  • Sara S Saad-Eldien, PhD

    Cairo university, faculty of physical therapy

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Amira Abd-elmonem, assist Prof. Physiacl therapy for pediatric department, faculty of physical therapy , Cairo university

Study Record Dates

First Submitted

August 4, 2021

First Posted

August 9, 2021

Study Start

October 20, 2020

Primary Completion

June 30, 2022

Study Completion

June 30, 2022

Last Updated

December 7, 2022

Record last verified: 2022-12

Locations